Compound Detail
CHEMBL4645514
Enter ChEMBL ID:
Free Research Context
This compound will appear in recent viewed items on the research home for this browser.
Research home
View demo workspace
CN1/C(=C/C=C2\CCCC(/C=C/C3=[N+](C)c4ccccc4C3(C)C)=C2N2CCN(c3ccc(-c4[nH]c5cc(F)cc6c5c4CCNC6=O)cc3)CC2)C(C)(C)c2ccccc21.[I-]
Basic Information
| ChEMBL ID | CHEMBL4645514 |
| Phase | Preclinical |
| Structure Type | MOL |
| InChI Key | QIUUJHYZYUVTNM-UHFFFAOYSA-N |
| Parent Compound | CHEMBL4650900 |
| Active Moiety | CHEMBL4650900 |
1
Targets
4
Activities
2
Assay Types
0
PK Parameters
2
Publications
0
Known Names
Molecular Properties
812.1
MW (Da)
10.32
ALogP
4
HBA
2
HBD
57.6
PSA (Ų)
0.17
QED
2
Ro5 Violations
6
Rot. Bonds
Drug Information
| Molecule Type | Unknown |
| Availability | Unknown |
| Chirality | Unknown |
Activity Summary
EC50 2 meas. best 7.25
IC50 2 meas. best 7.7
Target Activity Profile
Activity Data Samples
Top measurements by pChEMBL value
| Target | Type | Rel. | Value | Units | pChEMBL | Assay | PubMed |
|---|---|---|---|---|---|---|---|
| GBM | IC50 | = | 20.0 | nM | 7.7 | Synergistic antiproliferative activity against human patient derived GBM cells a... | 32527552 |
| GBM | IC50 | = | 21.0 | nM | 7.68 | Antiproliferative activity against human patient derived GBM cells assessed as r... | 32527552 |
| GBM | EC50 | = | 56.0 | nM | 7.25 | Synergistic cytotoxicity against human patient derived GBM cells assessed as red... | 32527552 |
| GBM | EC50 | = | 128.0 | nM | 6.89 | Cytotoxicity against human patient derived GBM cells assessed as reduction in ce... | 32527552 |
Literature References
| PubMed | DOI | Target Context | # Activities |
|---|---|---|---|
| 32527552 | 10.1016/j.bmcl.2020.127252 | GBM | 9 |
| 32527552 | 10.1016/j.bmcl.2020.127252 | Solute carrier organic anion transporter family member 1A2 | 2 |
Data from ChEMBL 36 via Core Engine